Trial intelligence / Profile preview

Effectiveness of metformin, DLBS 3233 and Vaccinium myrtillus extract in women with chronic PCOS

TCTR20221016001Phase 2Completed

Sponsor
Arifin Achmad Hospital
Start
Jan 2022
Modality
Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 2 trial of metformin, bilberry extract in polycystic ovary syndrome (PCOS), sponsored by Arifin Achmad Hospital. Started Jan 2022; status: completed.

02

Drugs

metforminbilberry extract
03

Conditions

polycystic ovary syndrome (PCOS)

Beyond the preview

Go deeper on TCTR20221016001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20221016001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call